Enfusion Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Nov 22 | SellUS$167,578 | Daniel Groman | Individual | 12,103 | US$14.06 | |
14 Nov 22 | SellUS$355,940 | Steven Bachert | Individual | 26,000 | US$13.69 | |
11 Nov 22 | SellUS$12,150,000 | Tarek Hammoud | Individual | 1,000,000 | US$12.15 |
Insider Trading Volume
Insider Buying: ENFN insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 3,639,297 | 5.0% |
Institutions | 26,494,548 | 36.3% |
VC/PE Firms | 42,762,789 | 58.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
31,297,606 | $375.6m | 0% | 91.94% | |||
9,009,594 | $108.1m | 0% | 1.19% | |||
6,490,000 | $77.9m | 0% | 1.84% | |||
4,975,183 | $59.7m | 0% | 0.25% | |||
4,340,559 | $52.1m | 81.49% | 0.55% | |||
2,419,831 | $29.0m | -2.95% | 0.01% | |||
1,870,386 | $22.4m | 0% | no data | |||
1,770,180 | $21.2m | -19.98% | 7.16% | |||
1,524,281 | $18.3m | 8.23% | no data | |||
1,508,076 | $18.1m | -4.83% | no data | |||
1,401,818 | $16.8m | 0% | no data | |||
1,336,823 | $16.0m | 0% | 0.01% | |||
676,973 | $8.1m | 17.7% | 0.01% | |||
595,936 | $7.2m | 0% | 0.01% | |||
525,637 | $6.3m | 6.37% | no data | |||
496,120 | $6.0m | 0% | no data | |||
439,774 | $5.3m | 0% | 0.59% | |||
337,197 | $4.0m | -13.39% | no data | |||
306,146 | $3.7m | 0% | 0.02% | |||
207,163 | $2.5m | -2.17% | no data | |||
190,332 | $2.3m | 0% | no data | |||
126,181 | $1.5m | 0% | no data | |||
81,743 | $980.9k | 0% | no data | |||
70,841 | $850.1k | -91.67% | no data | |||
69,155 | $829.9k | 2.06% | no data |